Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BRL29060A in Posttraumatic Stress Disorder

NCT00839397 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00839397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00839397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BRL29060A in Posttraumatic Stress Disorder
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2002
Completion date
June 30, 2005
Enrollment
52 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

post-traumatic stress disorder